Additionally, our conditional AAVR knock‐in mice could serve as an ideal model for studying AAV‐mediated gene therapy for acquired hearing loss and late‐onset genetic hearing loss, as AAVR knock‐in significantly extends the AAV treatment window. Here, KIAA0319L is linked to hearing loss disorder.